OS and PFS stratified by chemotherapy regimens in early-stage and advanced-stage diseases. OS (A) and PFS (B) of non–ANT-based regimens vs ANT-based regimens in early-stage patients before PSM. OS (C) and PFS (D) of non–ANT-based regimens vs ANT-based regimens in advanced-stage patients before PSM.